<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Katedavies on Ultrahuman Blog</title><link>https://www.ultrahuman.com/blog/author/katedavies/</link><description>Recent content in Katedavies on Ultrahuman Blog</description><generator>Hugo</generator><language>en-US</language><lastBuildDate>Wed, 03 Jun 2026 13:09:22 +0000</lastBuildDate><atom:link href="https://www.ultrahuman.com/blog/author/katedavies/index.xml" rel="self" type="application/rss+xml"/><item><title>Introducing Cycle &amp;amp; Ovulation Pro: Best-in class ovulation tracking for all cycles</title><link>https://www.ultrahuman.com/blog/introducing-cycle-ovulation-pro-best-in-class-ovulation-tracking-for-all-cycles/</link><pubDate>Fri, 15 Aug 2025 21:29:38 +0000</pubDate><guid>https://www.ultrahuman.com/blog/introducing-cycle-ovulation-pro-best-in-class-ovulation-tracking-for-all-cycles/</guid><description>&lt;p&gt;Ultrahuman, a global leader in wearable health technology, today announced its acquisition of viO HealthTech and the launch of &lt;strong&gt;Cycle &amp;amp; Ovulation Pro&lt;/strong&gt; for Ultrahuman Ring AIR.&lt;/p&gt;
&lt;p&gt;Rolling out now in the USA, UK, EU, Australia, and Canada as a groundbreaking new plug-in for Ultrahuman Ring AIR, Cycle &amp;amp; Ovulation Pro boasts best-in-class 90%+ accuracy for ovulation confirmation.&lt;/p&gt;
&lt;p&gt;Most menstrual tracking platforms are built for women with regular 28-day cycles. In reality, the majority have diverse cycle patterns – and those with conditions like non-bleeding, PCOS, endometriosis or thyroid disorders often don’t get an accurate or supportive experience. Ultrahuman’s acquisition of viO is designed for them.&lt;/p&gt;</description></item></channel></rss>